# FDA recall D-0570-2024

> **Medisca Inc.** · Class II · drug recall initiated 2024-06-26.

## Product

Budesonide, USP (Micronized), 500 mg, White to off-white odorless, crystalline powder, Medisca Inc., Plattsburgh, NY, 12901, USA, NDC: 38779-3097-00.

## Reason for recall

CGMP Deviations and Presence of Particulate Matter: Glass

## Distribution

Nationwide in the USA and Canada

## Key facts

- **Recall number:** D-0570-2024
- **Recalling firm:** Medisca Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Completed
- **Initiation date:** 2024-06-26
- **Report date:** 2024-07-10

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Irving, TX, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0570-2024

## Citation

> AI Analytics. FDA recall D-0570-2024. Retrieved 2026-06-23 from https://api.ai-analytics.org/recall/D-0570-2024. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*